Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

February 2028 67

  1. Study completion A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06305559

  2. Primary completion Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06310031

  3. Primary completion J-Valve Transfemoral Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06455787

  4. Study completion The PERSEVERE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06588634

  5. Study completion Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06788626

  6. Primary completion Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06788626

  7. Study completion A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06843577

  8. Study completion Developing a Digital Aid to Improve ICD Decisions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07084142

  9. Study completion A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282600

  10. Study completion Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07304817

  11. Primary completion Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07304817

  12. Primary completion HEARTS in Sync + CardioWatch 287-2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07322510

  13. Study completion Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444320

  14. Primary completion Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444320

  15. Primary completion Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07658807

  16. Study completion Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807423

  17. Primary completion Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807423

  18. Study completion A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07833098

  19. Study completion A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07913061

  20. Study completion Evaluating a Digital Aid to Improve ICD Decisions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07913204

  21. Primary completion Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06813911

  22. Study completion A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07610278

  23. Study completion Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096337

  24. Study completion A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07112872

  25. Primary completion A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07112872

  26. Study completion CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06886113

  27. Primary completion Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07149714

  28. Study completion Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06535568

  29. Study completion Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552194

  30. Primary completion A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07564414

  31. Study completion A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06268873

  32. Primary completion A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06268873

  33. Primary completion A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07670416

  34. Study completion Restoring Sinus Rhythm Using Dual-Shock Technique in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07560644

  35. Study completion Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05600374

  36. Primary completion Novel Approach to Conduction System Pacing With Use of Ultrasound Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06815783

  37. Study completion The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027891

  38. Study completion QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444086

  39. Study completion Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523620

  40. Study completion Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05268094

  41. Study completion Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06813911

  42. Primary completion Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor and Cognitive Deficits After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822140

  43. Study completion Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06987305

  44. Study completion Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07252544

  45. Primary completion Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07540416

  46. Study completion Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07653477

  47. Primary completion Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07653477

  48. Primary completion Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684469

  49. Study completion Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07759427

  50. Study completion Target Value Study to Evaluate the Safety and Efficacy of the Taurus NXT® Transcatheter Aortic Valve System for the Treatment of Severe Calcific Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908225

March 2028 88

  1. Study completion Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05488431

  2. Primary completion Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05488431

  3. Study completion STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05785897

  4. Primary completion Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06071429

  5. Study completion Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06095765

  6. Primary completion Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096909

  7. Study completion Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06401616

  8. Primary completion Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06401616

  9. Primary completion Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07168278

  10. Study completion Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07404670

  11. Primary completion Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07404670

  12. Primary completion Safety and Efficacy of J147 in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07430917

  13. Study completion Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441382

  14. Primary completion Ramadan Nutrition Plan (RNP) Education for Glycaemic Control in Older Adults With Type 2 Diabetes in Yogyakarta Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932210

  15. Primary completion CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02089607

  16. Primary completion Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03323476

  17. Study completion A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03477604

  18. Study completion Pulmonary Embolism International THrOmbolysis Study-3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04430569

  19. Primary completion The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04584632

  20. Primary completion MYTHS - MYocarditis THerapy With Steroids Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05150704

  21. Primary completion Bimanual Motor Skill Learning in Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05760846

  22. Study completion A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05911256

  23. Primary completion A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05911256

  24. Study completion Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078436

  25. Primary completion Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06723717

  26. Study completion SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06955260

  27. Primary completion CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06994975

  28. Study completion Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07223892

  29. Primary completion Functional Improvement in Subacute/Chronic Stroke Through Non-invasive Virtual-reality-Based Telerehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240948

  30. Study completion Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07246629

  31. Primary completion Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07246629

  32. Study completion QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441317

  33. Primary completion Trial Phase: Syndemic Adapted Medly Uganda Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07525271

  34. Primary completion Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07585968

  35. Study completion Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07699679

  36. Study completion Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07747402

  37. Primary completion Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07811934

  38. Primary completion Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07812350

  39. Primary completion Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07824323

  40. Study completion Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07828730

  41. Study completion Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890818

  42. Primary completion Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890818

  43. Primary completion Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05611242

  44. Study completion Ramadan Nutrition Plan (RNP) Education for Glycaemic Control in Older Adults With Type 2 Diabetes in Yogyakarta Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932210

  45. Primary completion Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07604922

  46. Study completion A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07670416

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04744571

  2. Study completion Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04970238

  3. Primary completion Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04970238

  4. Study completion Assessment of Intracerebral Hematoma Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158660

  5. Study start Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05589454

  6. Primary completion Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke Registry record

    Expected 2023-02-01; that period ended on 2023-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05652751

  7. Study start Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia Registry record

    Expected 2023-02-01; that period ended on 2023-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691257

  8. Study start Safety and Efficacy of Evolocumab in Ischemic Stroke Registry record

    Expected 2023-02-01; that period ended on 2023-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05697185

  9. Study start rTMS in Chronic Poststroke Dysphagia Registry record

    Expected 2023-02-05; that period ended on 2023-02-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05590819

  10. Study start Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD Registry record

    Expected 2023-02-06; that period ended on 2023-02-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580510

  11. Study start Research on Diagnosis and Prognosis of Myocardial Ischemia Level Using Magnetocardiography Registry record

    Expected 2023-02-15; that period ended on 2023-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718206

  12. Primary completion Early Vascular Adjustments During Hypertensive Pregnancy Registry record

    Expected 2023-02; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02531490

  13. Study completion Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Registry record

    Expected 2023-02-28; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04696120

  14. Study completion Prophylactic Amiodarone for Shockable Cardiac Arrest Registry record

    Expected 2023-02-28; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04845607

  15. Primary completion Prophylactic Amiodarone for Shockable Cardiac Arrest Registry record

    Expected 2023-02-28; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04845607

  16. Study completion Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction Registry record

    Expected 2023-02; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060588

  17. Study completion BUN/Cr-based Hydration Therapy to Improve Outcome of Patients With Acute Ischemic Stroke Registry record

    Expected 2023-02-28; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05121389

  18. Study start Safety Study of Intracranial Support Catheter and Guide Catheter for Stent-Assisted Embolization in the Treatment of Intracranial Aneurysms Registry record

    Expected 2023-02; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05524285

  19. Study start The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes Registry record

    Expected 2023-02; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05719376

  20. Study start A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Registry record

    Expected 2023-02-28; that period ended on 2023-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05759897

  21. Primary completion Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients Registry record

    Expected 2023-03-01; that period ended on 2023-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04135287

  22. Primary completion Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Registry record

    Expected 2023-03-01; that period ended on 2023-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04661709

  23. Primary completion Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2023-03-01; that period ended on 2023-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04714177

  24. Study start Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record

    Expected 2023-03-01; that period ended on 2023-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05745311

  25. Primary completion Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock Registry record

    Expected 2023-03-03; that period ended on 2023-03-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03813134

  26. Primary completion TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon Registry record

    Expected 2023-03-10; that period ended on 2023-03-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03913832

  27. Primary completion Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA) Registry record

    Expected 2023-03-15; that period ended on 2023-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05282836

  28. Study start Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. Registry record

    Expected 2023-03-15; that period ended on 2023-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05760456

  29. Study completion Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients Registry record

    Expected 2023-03-23; that period ended on 2023-03-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04932928

  30. Study completion A Non-Traumatic Binder for Temporary Abdominal Wall Closure Registry record

    Expected 2023-03-30; that period ended on 2023-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03815370

  31. Study completion Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients:a Prospective, Multicenter, Randomized Controlled Trial Registry record

    Expected 2023-03-30; that period ended on 2023-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04475978

  32. Primary completion A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke Registry record

    Expected 2023-03-30; that period ended on 2023-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05188417

  33. Study completion Sodium Thiosulfate to Preserve Cardiac Function in STEMI Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02899364

  34. Study completion Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke Registry record

    Expected 2023-03-31; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03045055

  35. Study completion Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04346004

  36. Primary completion Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04346004

  37. Study completion Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Registry record

    Expected 2023-03-31; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04491695

  38. Study start Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04603508

  39. Primary completion Remote Blood Pressure Management Clinical Application Research Registry record

    Expected 2023-03-31; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04690478

  40. Primary completion An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05089435

  41. Primary completion Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05217485

  42. Study start Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05373004

  43. Study start CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05508256

  44. Primary completion TWIN2WIN (Double Stent (DS-EVT) Versus Primary Thrombectomy With One Stent (SS-EVT)) Registry record

    Expected 2023-03; that period ended on 2023-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05632458

  45. Study completion Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05124353

  46. Primary completion Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05124353

  47. Primary completion Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05298475

  48. Primary completion Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05354297

  49. Study start NanO2 for Large Vessel Occlusion Stroke Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389748

  50. Study start Follow up of Clinical Outcome of Deferred vs Immediate Stenting in High Thrombus Stemi Patients Registry record

    Expected 2023-04-01; that period ended on 2023-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05793671

  51. Study start Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk Registry record

    Expected 2023-04-05; that period ended on 2023-04-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487950

  52. Study start The Effects of Allicor on Patients After Revascularization Treatment During a Year Registry record

    Expected 2023-04-20; that period ended on 2023-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05813171

  53. Study completion The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial) Registry record

    Expected 2023-04-22; that period ended on 2023-04-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05371366

  54. Primary completion The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial) Registry record

    Expected 2023-04-22; that period ended on 2023-04-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05371366

  55. Study completion Early Vascular Adjustments During Hypertensive Pregnancy Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02531490

  56. Primary completion Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04079192

  57. Primary completion Prevention of Post-Operative Cardiac Arrhythmias Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04234906

  58. Study completion Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04523545

  59. Primary completion Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04523545

  60. Primary completion Endovascular Treatment and RIPC in Acute Ischemic Stroke Registry record

    Expected 2023-04-30; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04581759

  61. Study completion A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease Registry record

    Expected 2023-04; that period ended on 2023-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04953117

  62. Study completion Mobile Health to Enhance Exercise in Type 2 Diabetes Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04653532

  63. Primary completion Cryoablation With Vestibular Expansion for the Treatment of Paroxysmal/Short-course Persistent Atrial Fibrillation Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05311098

  64. Primary completion Clinical Trial in China Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580952

  65. Study completion Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05709509

  66. Primary completion Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05709509

  67. Study start A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05783557

  68. Study start The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820048

  69. Study start tDCS and rTMS in Patients With Early Disorders of Consciousness Registry record

    Expected 2023-05-01; that period ended on 2023-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820178

  70. Primary completion Screening of OSA in Hospitalized Stroke Patients Using BSP Registry record

    Expected 2023-05-03; that period ended on 2023-05-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466864

  71. Study completion Impact of NIRS-guided Cardiopulmonary Resuscitation After Cardiac Arrest on Resuscitation Rate Registry record

    Expected 2023-05-05; that period ended on 2023-05-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03911908

  72. Study completion Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes Registry record

    Expected 2023-05-10; that period ended on 2023-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05440591

  73. Primary completion Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes Registry record

    Expected 2023-05-10; that period ended on 2023-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05440591

  74. Primary completion Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Registry record

    Expected 2023-05-15; that period ended on 2023-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04976283

  75. Primary completion Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury Registry record

    Expected 2023-05-17; that period ended on 2023-05-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05399576

  76. Study completion Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung Registry record

    Expected 2023-05-30; that period ended on 2023-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05657769

  77. Primary completion Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung Registry record

    Expected 2023-05-30; that period ended on 2023-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05657769

  78. Primary completion The Safety and Efficacy of the Suture-Mediated Closure System Registry record

    Expected 2023-05-30; that period ended on 2023-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05841836

  79. Study completion The Adult Hemorrhagic Moyamoya Surgery Study Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02319980

  80. Primary completion The Adult Hemorrhagic Moyamoya Surgery Study Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02319980

  81. Study completion Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study) Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02494895

  82. Primary completion Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study) Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02494895

  83. Primary completion Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02988245

  84. Study completion Strengthening Referral Networks for Management of Hypertension Across the Health System (STRENGTHS) Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03543787

  85. Primary completion Strengthening Referral Networks for Management of Hypertension Across the Health System (STRENGTHS) Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03543787

  86. Study completion Atrial Sensing Capability for Better Detection of Atrial Fibrillation Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03932604

  87. Primary completion Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04090281

  88. Study completion Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04415164

  89. Study start Semaglutide to Reduce Atrial Fibrillation Burden Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05209165

  90. Study completion Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure Registry record

    Expected 2023-05-31; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05232292

  91. Primary completion Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05626972

  92. Study start Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain Registry record

    Expected 2023-05; that period ended on 2023-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05857904

  93. Primary completion Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03423511

  94. Study completion Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04100434

  95. Primary completion Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04171726

  96. Study completion Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04340908

  97. Study completion Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04661709

  98. Study completion Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05652751

  99. Study start Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05841654

  100. Study start A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record

    Expected 2023-06-01; that period ended on 2023-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05843162